Marlborough, Massachusetts – October 28, 2019 – GE Healthcare Life Sciences is launching KUBio™ box, a fully-integrated, flexible, and adaptable biomanufacturing environment to accelerate the production of viral vector-based gene therapies. The latest addition to the KUBio modular bioprocessing portfolio, KUBio box is expected to speed gene therapies to market and contribute to increased capacity... Read more
Lab will support acceleration of biotechnology, health and life sciences research in the UK Companies to gain access to fully-equipped lab with the latest GE Healthcare Life Sciences technologies Cheshire, United Kingdom, 23 October 2019 – GE Healthcare Life Sciences will inaugurate an open-access lab at Alderley Park’s Mereside Campus, the UK’s largest single-site life... Read more
CHICAGO, IL and CHARLOTTE, N.C. (October 16, 2019) – GE Healthcare and Premier Inc. (NASDAQ: PINC) announced a collaboration to develop a model to bring a same-day breast cancer diagnosis and treatment model to the United States. A similar model has already proven effective at the Gustave Roussy Cancer Campus in France. Launched in 2004,... Read more
230 medical imaging units will be replaced and updated within first four years Equipment will support the public health system’s goal of standardizing care and providing patients modernized, state-of-the-art imaging technology New York, NY – October 10, 2019 –NYC Health + Hospitals today announced that it is investing $224 million over ten-years to upgrade medical imaging technology... Read more
Theragnostics’ novel PET tracer, GalliProst, will help visualize prostate cancer to enable personalized treatment. The two companies will leverage their combined scientific, commercial and market access expertise to work towards a commercial launch. Chalfont St Giles, UK – October 9th 2019 – GE Healthcare and Theragnostics have entered into a global commercial partnership for a... Read more
MIT (Massachussetts Institute of Technology), one of the best universities in the world launches its MIT Catalyst program in collaboration with GE Healthcare at first in the region in Hungary at the University of Debrecen. The Hungarian Hub formed with the support of GE will create a European-Transatlantic partnership enabling the creation and support of... Read more
Developed by scientists for scientists – first patent issued 2009 for this product Flexibility of system allows for custom biomarker panel design and whole slide imaging Precise image registration enables spatial and quantititative biomarker analysis (Paris, France and Seattle, Washington) September 26, 2019 – GE Healthcare launches Cell DIVE™ multiplexed imaging, an anti-body based solution... Read more
Partnering with multiple companies to develop targeted PET imaging tracers to better predict and monitor individual patient response to immunotherapies PET tracers would help increase patient response rates which currently average between 20-40% Initially PET tracers would support pharma companies to enhance clinical trials enabling speed-to-market for immunotherapies Chalfont St Giles, UK –September 24 2019... Read more
• Gives fast, deep and clear images for live observation over long periods • Scientists can study a larger range of applications thanks to multiple imaging modes integrated on one device – saving the need for multiple instruments. • EDGE Confocal imaging allows deeper imaging into samples, tissues or organisms Seattle, Washington, September 18, 2019 –... Read more
“X-ray – the world’s oldest form of medical imaging – just got a whole lot smarter, and soon, the rest of our offerings will too,” says Kieran Murphy, President & CEO, GE Healthcare. “GE Healthcare is leading the way in the creation of AI applications for diagnostic imaging and taking what was once a promise... Read more